Skip to main content

Advertisement

Table 2 Comorbidity in the investigated patient groups

From: No evidence of enhanced oxidant production in blood obtained from patients with obstructive sleep apnea

Disease Number of patients with a given disease
  OSAS n = 27 CPAP-OSAS n = 22 Controls n = 11
Arterial hypertension 16 16 4
Ischemic heart disease 7 7 2
Diabetes 2 4 0
Gout 0 4 0
  1. OSAS – patients with untreated OSAS; CPAP-OSAS – patients with OSAS treated successfully after a first attempt with CPAP, controls – subjects without OSAS.